Resistin is a prognostic factor for death in type 2 diabetes
Diabetes/Metabolism Research and Reviews2018Vol. 35(2), pp. e3098–e3098
Citations Over TimeTop 11% of 2018 papers
Agnieszka Kapłon‐Cieślicka, Agata Tymińska, Marek Rosiak, Krzysztof Ozierański, Michał Peller, Ceren Eyileten, Agnieszka Kondracka, Justyna Pordzik, Dagmara Mirowska-Guzeł, Grzegorz Opolski, Marek Postuła, Krzysztof J. Filipiak
Abstract
Higher resistin is associated with reduced survival in T2D, irrespectively of TNF-α. Resistin concentration of above 11 ng/mL indicates T2D patients at an increased risk of unfavourable outcomes. Leptin was not a prognostic factor. These results suggest that in T2D, association of resistin with unfavourable outcomes might, at least in part, result from its pro-inflammatory properties.
Related Papers
- → Sexual Dimorphism and Regulation of Resistin, Adiponectin, and Leptin Expression in the Mouse(2004)155 cited
- → Long-Term Effects of Central Leptin and Resistin on Body Weight, Insulin Resistance, and β-Cell Function and Mass by the Modulation of Hypothalamic Leptin and Insulin Signaling(2007)73 cited
- → Diet/ExerciseVersusPioglitazone: Effects of Insulin Sensitization with Decreasing or Increasing Fat Mass on Adipokines and Inflammatory Markers(2006)44 cited
- → Supraphysiological Triiodothyronine Doses Diminish Leptin and Adiponectin Gene Expression, but do not Alter Resistin Expression in Calorie Restricted Obese Rats(2011)17 cited
- Resistin gene overexpression in adipose tissue of SD rats with high-fat diet and its correlation with leptin and insulin(2003)